Sunday, December 06, 2020 5:16:45 PM
1. https://www.sec.gov/Archives/edgar/data/1701251/000167025417000251/document_11.pdf
*See Slide 9
2. Google "Fuzeon" from slide 9. It is a peptide drug similar to clone 3 that ENZC is developing, but far less effective.
3. Who owns Fuzeon you might ask? Genentech. Who went on to get acquired by Roche Holdings for $47B, ticker = RHHBY. It now trades for $43.68...
How much will people pay for a treatment over twice as effective?
Get comfortable folks. This is only the beginning.
All of my posts are opinion. Do your own due diligence, I provide no financial advice.
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM